Patient-Derived Cancer Models

Maria Flavia Di Renzo; Simona Corso

doi:10.3390/cancers12123779

Patient-Derived Cancer Models

Maria Flavia Di Renzo, Simona Corso

Istituto Oncologico Candiolo

Research output: Contribution to journal › Article › peer-review

Abstract

For many decades, basic and preclinical cancer research has been based on the use of established, commercially available cell lines, originally derived from patients' samples but adapted to grow indefinitely in artificial culture conditions, and on xenograft models developed by injection of these cells in immunocompromised animals [...].

Original language	English
Journal	Cancers
Volume	12
Issue number	12
DOIs	https://doi.org/10.3390/cancers12123779
Publication status	Published - Dec 15 2020

Access to Document

10.3390/cancers12123779

Cite this

@article{a9a4af5b10094ecf9f808d00adc0366e,

title = "Patient-Derived Cancer Models",

abstract = "For many decades, basic and preclinical cancer research has been based on the use of established, commercially available cell lines, originally derived from patients' samples but adapted to grow indefinitely in artificial culture conditions, and on xenograft models developed by injection of these cells in immunocompromised animals [...].",

author = "{Di Renzo}, {Maria Flavia} and Simona Corso",

year = "2020",

month = dec,

day = "15",

doi = "10.3390/cancers12123779",

language = "English",

volume = "12",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI AG",

number = "12",

}

TY - JOUR

T1 - Patient-Derived Cancer Models

AU - Di Renzo, Maria Flavia

AU - Corso, Simona

PY - 2020/12/15

Y1 - 2020/12/15

N2 - For many decades, basic and preclinical cancer research has been based on the use of established, commercially available cell lines, originally derived from patients' samples but adapted to grow indefinitely in artificial culture conditions, and on xenograft models developed by injection of these cells in immunocompromised animals [...].

AB - For many decades, basic and preclinical cancer research has been based on the use of established, commercially available cell lines, originally derived from patients' samples but adapted to grow indefinitely in artificial culture conditions, and on xenograft models developed by injection of these cells in immunocompromised animals [...].

U2 - 10.3390/cancers12123779

DO - 10.3390/cancers12123779

M3 - Article

C2 - 33333972

VL - 12

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 12

ER -

Patient-Derived Cancer Models

Abstract

Access to Document

Fingerprint

Cite this